PHYTONADIONE

PHYTONADIONE was reported 8631 times

PHYTONADIONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPENDICOLITH 275 0.7106
1 SLEEP DISORDER THERAPY 139 0.7020
2 ANTACID THERAPY 89 0.6846
3 ANALGESIC THERAPY 136 0.4237
4 DRUG THERAPY 123 0.3628
5 ANTICOAGULANT THERAPY 86 0.3028
6 CONGENITAL HIATUS HERNIA 60 0.2632
7 MALIGNANT MELANOMA STAGE 0 47 0.2249
8 BACTEROIDES INFECTION 42 0.1609
9 HYPER IGE SYNDROME 17 0.1491
10 HYPERPHOSPHATAEMIA 173 0.0804
11 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 67 0.0723
12 BLOOD PHOSPHORUS INCREASED 192 0.0703
13 FACTOR V INHIBITION 13 0.0670
14 CUTANEOUS MUCORMYCOSIS 11 0.0598
15 TOTAL LUNG CAPACITY DECREASED 73 0.0457
16 VITAMIN K DEFICIENCY 18 0.0448
17 RESTRICTIVE CARDIOMYOPATHY 11 0.0363
18 NECROTISING ENTEROCOLITIS NEONATAL 13 0.0320
19 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 162 0.0320
20 IRON DEFICIENCY 137 0.0304
21 APPENDICITIS 284 0.0304
22 BLOOD URIC ACID INCREASED 160 0.0277
23 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 143 0.0262
24 HYPOPHOSPHATAEMIA 188 0.0254
25 AORTIC STENOSIS 88 0.0252
26 LUNG OPACITY 65 0.0246
27 MYASTHENIA GRAVIS 192 0.0237
28 VENTRICULAR FIBRILLATION 261 0.0235
29 HYPHAEMA 12 0.0230
30 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 10 0.0206
31 CARDIOGENIC SHOCK 280 0.0195
32 PLEURITIC PAIN 51 0.0185
33 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 15 0.0168
34 RESPIRATORY SYMPTOM 43 0.0151
35 JAUNDICE NEONATAL 28 0.0148
36 NIPPLE DISORDER 9 0.0145
37 TROPONIN INCREASED 104 0.0137
38 ENTEROCOCCAL SEPSIS 11 0.0136
39 MULTIPLE ORGAN DYSFUNCTION SYNDROME 366 0.0129
40 ASCITES 377 0.0128
41 BLOOD FIBRINOGEN INCREASED 10 0.0127
42 CYSTIC FIBROSIS 69 0.0125
43 COAGULATION TIME PROLONGED 19 0.0123
44 C-REACTIVE PROTEIN DECREASED 8 0.0123
45 BLOOD CALCIUM INCREASED 107 0.0122
46 BENIGN PROSTATIC HYPERPLASIA 61 0.0118
47 DISCOLOURED VOMIT 11 0.0114
48 SEPSIS NEONATAL 9 0.0111
49 BREATH SOUNDS ABNORMAL 53 0.0107
50 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 178 0.0104
51 BACTERIAL INFECTION 192 0.0103
52 LIMB MALFORMATION 8 0.0101
53 CHOROIDAL EFFUSION 8 0.0100
54 HEART TRANSPLANT 9 0.0099
55 PNEUMONIA STAPHYLOCOCCAL 19 0.0096
56 NEONATAL DISORDER 15 0.0095
57 HYPERLIPIDAEMIA 111 0.0093
58 INTESTINAL DILATATION 12 0.0090
59 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 13 0.0085
60 DYSMORPHISM 19 0.0081
61 KLEBSIELLA SEPSIS 9 0.0080
62 EPICONDYLITIS 12 0.0079
63 GASTRIC PH DECREASED 8 0.0078
64 HEPATORENAL SYNDROME 13 0.0077
65 ULCER 122 0.0077
66 NEURALGIA 184 0.0076
67 HAEMATOMA MUSCLE 9 0.0075
68 BLOOD TEST ABNORMAL 105 0.0075
69 GOUT 133 0.0074
70 ASTIGMATISM 11 0.0073
71 COAGULOPATHY 120 0.0072
72 BRADYCARDIA NEONATAL 9 0.0072
73 HYPOTONIA NEONATAL 11 0.0070
74 INTENSIVE CARE 10 0.0070
75 DYSLEXIA 8 0.0069
76 ESCHERICHIA BACTERAEMIA 16 0.0068
77 END STAGE RENAL DISEASE 123 0.0067
78 SPEECH DISORDER DEVELOPMENTAL 19 0.0066
79 RALES 38 0.0065
80 INTERNATIONAL NORMALISED RATIO INCREASED 186 0.0065
81 RHONCHI 9 0.0065
82 PERITONEAL HAEMORRHAGE 9 0.0065
83 PORTAL HYPERTENSION 20 0.0065
84 BILIRUBIN CONJUGATED INCREASED 15 0.0064
85 PROTHROMBIN TIME PROLONGED 38 0.0063
86 ASPIRATION 69 0.0063
87 PANCREATIC FAILURE 11 0.0062
88 LEARNING DISORDER 15 0.0062
89 HYPOGLYCAEMIA NEONATAL 10 0.0062
90 PULMONARY FUNCTION TEST DECREASED 27 0.0062
91 HYPONATRAEMIA 346 0.0061
92 SYSTEMIC CANDIDA 15 0.0060
93 BRONCHIECTASIS 39 0.0058
94 MICTURITION URGENCY 66 0.0058
95 HYPERCHOLESTEROLAEMIA 55 0.0057
96 STAPHYLOCOCCUS TEST POSITIVE 12 0.0057
97 JUGULAR VEIN THROMBOSIS 10 0.0056
98 LIVER TRANSPLANT 20 0.0055
99 INTERNATIONAL NORMALISED RATIO FLUCTUATION 11 0.0053
100 FULL BLOOD COUNT ABNORMAL 56 0.0053
101 TOXIC EPIDERMAL NECROLYSIS 80 0.0053
102 GENITAL HERPES 8 0.0052
103 LANGUAGE DISORDER 11 0.0051
104 PANCREATITIS CHRONIC 12 0.0051
105 VENOOCCLUSIVE LIVER DISEASE 25 0.0051
106 RETROPERITONEAL HAEMATOMA 11 0.0050
107 REGURGITATION 17 0.0049
108 HYPERBILIRUBINAEMIA 51 0.0049
109 ACUTE HEPATIC FAILURE 67 0.0049
110 VASCULAR DEVICE INFECTION 22 0.0048
111 SPUTUM DISCOLOURED 45 0.0047
112 VITAMIN B12 DEFICIENCY 19 0.0047
113 APLASTIC ANAEMIA 24 0.0046
114 TRANSAMINASES INCREASED 101 0.0045
115 KYPHOSIS 8 0.0045
116 HYPERLACTACIDAEMIA 12 0.0045
117 INTRAVENTRICULAR HAEMORRHAGE 11 0.0044
118 SEPSIS 493 0.0044
119 CALCIPHYLAXIS 8 0.0044
120 NEUTROPENIC COLITIS 9 0.0043
121 PSYCHOMOTOR RETARDATION 12 0.0043
122 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 11 0.0043
123 HEPARIN-INDUCED THROMBOCYTOPENIA 21 0.0043
124 HYPERNATRAEMIA 21 0.0042
125 BLOOD CHOLESTEROL INCREASED 195 0.0042
126 SPUTUM INCREASED 9 0.0042
127 INTERNATIONAL NORMALISED RATIO DECREASED 16 0.0039
128 ABDOMINAL DISTENSION 411 0.0039
129 LUNG CONSOLIDATION 11 0.0039
130 OLIGOHYDRAMNIOS 13 0.0039
131 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 203 0.0039
132 LIVER FUNCTION TEST INCREASED 83 0.0039
133 CHOLESTASIS 74 0.0038
134 ABDOMINAL TENDERNESS 19 0.0038
135 INTRA-ABDOMINAL HAEMORRHAGE 9 0.0038
136 DISSEMINATED INTRAVASCULAR COAGULATION 53 0.0038
137 HEPATIC ENCEPHALOPATHY 35 0.0037
138 VENOOCCLUSIVE DISEASE 9 0.0036
139 PULMONARY HAEMORRHAGE 28 0.0036
140 FEBRILE BONE MARROW APLASIA 15 0.0035
141 MULTI-ORGAN FAILURE 61 0.0035
142 FINE MOTOR SKILL DYSFUNCTION 10 0.0035
143 TUMOUR LYSIS SYNDROME 30 0.0034
144 BACTERAEMIA 40 0.0034
145 MYOPIA 8 0.0034
146 HAEMOPTYSIS 93 0.0033
147 ENTEROCOCCAL INFECTION 16 0.0033
148 FOETAL GROWTH RESTRICTION 20 0.0033
149 HEPATIC FAILURE 99 0.0033
150 HAEMODYNAMIC INSTABILITY 25 0.0033
151 EXPOSURE VIA BREAST MILK 13 0.0033
152 BLOOD BILIRUBIN INCREASED 86 0.0032
153 GENERAL PHYSICAL HEALTH DETERIORATION 367 0.0032
154 SLEEP DISORDER 223 0.0032
155 PULSELESS ELECTRICAL ACTIVITY 13 0.0031
156 JOINT INJURY 66 0.0031
157 BACTERIAL SEPSIS 10 0.0031
158 STRABISMUS 9 0.0031
159 OBSTRUCTIVE AIRWAYS DISORDER 34 0.0031
160 PSYCHOMOTOR SKILLS IMPAIRED 8 0.0031
161 PNEUMONIA FUNGAL 12 0.0030
162 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 18 0.0030
163 GASTRITIS EROSIVE 14 0.0030
164 POTENTIATING DRUG INTERACTION 10 0.0030
165 DRY MOUTH 239 0.0029
166 ABDOMINAL ABSCESS 13 0.0029
167 LOWER RESPIRATORY TRACT INFECTION 133 0.0029
168 BRAIN DEATH 9 0.0029
169 BLOOD ALBUMIN DECREASED 23 0.0029
170 ATELECTASIS 28 0.0029
171 TALIPES 9 0.0029
172 PULMONARY MASS 43 0.0029
173 BLOOD CREATININE DECREASED 9 0.0029
174 THROMBOSIS 229 0.0028
175 TESTICULAR PAIN 9 0.0028
176 HYPOALBUMINAEMIA 22 0.0028
177 SHOCK HAEMORRHAGIC 23 0.0028
178 FORCED EXPIRATORY VOLUME DECREASED 8 0.0028
179 ASPARTATE AMINOTRANSFERASE INCREASED 149 0.0028
180 PLEURAL EFFUSION 170 0.0028
181 BEHAVIOUR DISORDER 15 0.0028
182 ACUTE RESPIRATORY DISTRESS SYNDROME 49 0.0028
183 LOW BIRTH WEIGHT BABY 22 0.0028
184 DIABETES MELLITUS 210 0.0028
185 PULMONARY EMBOLISM 260 0.0027
186 SUBDURAL HAEMATOMA 39 0.0027
187 JAUNDICE 73 0.0027
188 NEUTROPENIC SEPSIS 19 0.0027
189 BLOOD ALKALINE PHOSPHATASE INCREASED 66 0.0027
190 OROPHARYNGEAL DISCOMFORT 24 0.0027
191 PROTEIN TOTAL DECREASED 10 0.0027
192 URINE ABNORMALITY 12 0.0026
193 MALNUTRITION 29 0.0026
194 MOUTH HAEMORRHAGE 19 0.0026
195 ESCHERICHIA URINARY TRACT INFECTION 11 0.0026
196 FAECES HARD 10 0.0026
197 DYSLIPIDAEMIA 13 0.0026
198 BRONCHIOLITIS 9 0.0026
199 SEPTIC SHOCK 111 0.0025
200 JAUNDICE CHOLESTATIC 9 0.0025
201 NEONATAL RESPIRATORY DISTRESS SYNDROME 9 0.0025
202 AUTISM SPECTRUM DISORDER 14 0.0025
203 PANCREATITIS ACUTE 57 0.0025
204 BLOOD CREATININE INCREASED 164 0.0025
205 ACUTE RESPIRATORY FAILURE 48 0.0025
206 IRON DEFICIENCY ANAEMIA 23 0.0025
207 ACIDOSIS 19 0.0025
208 SPLENOMEGALY 29 0.0025
209 ILEUS PARALYTIC 11 0.0025
210 HEPATITIS ACUTE 16 0.0025
211 CYTOKINE RELEASE SYNDROME 49 0.0024
212 CARDIOVASCULAR DISORDER 62 0.0024
213 WOUND HAEMORRHAGE 9 0.0024
214 BLOOD MAGNESIUM DECREASED 21 0.0024
215 STAPHYLOCOCCAL SEPSIS 12 0.0024
216 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 8 0.0024
217 HYPOXIA 85 0.0024
218 HYPOVOLAEMIA 14 0.0024
219 CEREBRAL HAEMATOMA 8 0.0024
220 ATTENTION DEFICIT HYPERACTIVITY DISORDER 10 0.0024
221 PURPURA 21 0.0024
222 SWELLING 222 0.0024
223 INTENTIONAL PRODUCT MISUSE 207 0.0024
224 INJURY ASSOCIATED WITH DEVICE 48 0.0024
225 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 40 0.0024
226 HEPATIC FIBROSIS 8 0.0023
227 INTERNATIONAL NORMALISED RATIO ABNORMAL 8 0.0023
228 STAPHYLOCOCCAL BACTERAEMIA 10 0.0023
229 METABOLIC ACIDOSIS 73 0.0023
230 HAEMATOMA 59 0.0023
231 BLOOD CREATINE INCREASED 10 0.0023
232 AZOTAEMIA 9 0.0023
233 ENTEROCOLITIS 13 0.0022
234 FIBRIN D DIMER INCREASED 8 0.0022
235 BLOOD UREA INCREASED 37 0.0022
236 BLOOD PHOSPHORUS DECREASED 8 0.0022
237 INTESTINAL ISCHAEMIA 12 0.0022
238 PRODUCTIVE COUGH 103 0.0022
239 AUTOIMMUNE HEPATITIS 15 0.0022
240 AMMONIA INCREASED 11 0.0022
241 HAEMORRHAGE INTRACRANIAL 32 0.0021
242 HEPATOMEGALY 21 0.0021
243 FAILURE TO THRIVE 11 0.0021
244 INCORRECT DRUG ADMINISTRATION RATE 9 0.0021
245 SMALL INTESTINAL OBSTRUCTION 26 0.0021
246 PULSE ABSENT 10 0.0021
247 PSEUDOMONAS INFECTION 18 0.0021
248 CONSTIPATION 457 0.0021
249 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 20 0.0021
250 CONJUNCTIVAL HAEMORRHAGE 8 0.0021
251 GASTROINTESTINAL PAIN 23 0.0021
252 ANAEMIA 397 0.0021
253 POST PROCEDURAL HAEMORRHAGE 24 0.0021
254 TACHYPNOEA 28 0.0021
255 DIVERTICULUM INTESTINAL 9 0.0021
256 APNOEA 16 0.0021
257 VITAMIN D DEFICIENCY 20 0.0020
258 CORONARY ARTERY DISEASE 62 0.0020
259 ECCHYMOSIS 14 0.0020
260 ABDOMINAL PAIN 475 0.0020
261 TORSADE DE POINTES 16 0.0020
262 COVID-19 PNEUMONIA 24 0.0020
263 FLANK PAIN 19 0.0020
264 DERMATITIS EXFOLIATIVE 10 0.0020
265 FEBRILE NEUTROPENIA 132 0.0020
266 HEPATOCELLULAR INJURY 28 0.0020
267 DYSGRAPHIA 13 0.0020
268 INGUINAL HERNIA 12 0.0020
269 HEPATIC CIRRHOSIS 37 0.0020
270 EAR DISORDER 9 0.0020
271 SUBARACHNOID HAEMORRHAGE 20 0.0020
272 ENCEPHALOPATHY 48 0.0020
273 ATRIAL SEPTAL DEFECT 16 0.0019
274 HYPOKALAEMIA 88 0.0019
275 DRUG INTOLERANCE 184 0.0019
276 UPPER GASTROINTESTINAL HAEMORRHAGE 32 0.0019
277 SENSITIVITY TO WEATHER CHANGE 10 0.0019
278 GAMMA-GLUTAMYLTRANSFERASE INCREASED 42 0.0019
279 CLOSTRIDIUM DIFFICILE COLITIS 20 0.0019
280 UPPER RESPIRATORY TRACT INFECTION 87 0.0019
281 HYPOVOLAEMIC SHOCK 9 0.0019
282 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 14 0.0019
283 INFUSION SITE PAIN 24 0.0019
284 OCULAR ICTERUS 8 0.0018
285 THROMBOCYTOPENIA 206 0.0018
286 URINE OUTPUT DECREASED 16 0.0018
287 PREMATURE BABY 55 0.0018
288 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 47 0.0018
289 LIVER DISORDER 81 0.0018
290 HYPERVOLAEMIA 9 0.0018
291 HAEMOLYSIS 14 0.0018
292 BRONCHOPULMONARY ASPERGILLOSIS 14 0.0018
293 WHEEZING 107 0.0018
294 FLUID INTAKE REDUCED 9 0.0018
295 RESPIRATORY FAILURE 131 0.0018
296 INTRACRANIAL PRESSURE INCREASED 10 0.0018
297 TRANSIENT ISCHAEMIC ATTACK 60 0.0018
298 SUPRAVENTRICULAR TACHYCARDIA 17 0.0018
299 CHOLANGITIS 11 0.0018
300 PULMONARY FIBROSIS 34 0.0018
301 EPSTEIN-BARR VIRUS INFECTION 11 0.0018
302 CEREBRAL ISCHAEMIA 9 0.0017
303 SKIN NECROSIS 9 0.0017
304 NEPHROGENIC ANAEMIA 8 0.0017
305 FEEDING DISORDER 35 0.0017
306 PAROSMIA 13 0.0017
307 DECUBITUS ULCER 14 0.0017
308 SPINAL FRACTURE 34 0.0017
309 EMBOLISM 14 0.0017
310 ANAL ABSCESS 9 0.0017
311 STAPHYLOCOCCAL INFECTION 55 0.0017
312 APHAGIA 8 0.0017
313 FOETAL EXPOSURE DURING PREGNANCY 135 0.0017
314 HAEMATEMESIS 42 0.0017
315 MUSCULOSKELETAL STIFFNESS 145 0.0017
316 NOCTURIA 20 0.0016
317 COLITIS ISCHAEMIC 11 0.0016
318 RENAL FAILURE ACUTE 69 0.0016
319 DRUG-INDUCED LIVER INJURY 51 0.0016
320 OEDEMA PERIPHERAL 198 0.0016
321 FOOT DEFORMITY 18 0.0016
322 GENERAL PHYSICAL CONDITION ABNORMAL 11 0.0016
323 SINUS TACHYCARDIA 23 0.0016
324 LUNG DISORDER 79 0.0016
325 HEPATIC ENZYME ABNORMAL 8 0.0016
326 BLOOD CALCIUM DECREASED 18 0.0016
327 RESPIRATION ABNORMAL 11 0.0016
328 SOMNOLENCE 321 0.0016
329 EPISTAXIS 119 0.0016
330 BLOOD LACTATE DEHYDROGENASE INCREASED 25 0.0016
331 LIPASE INCREASED 12 0.0016
332 MATERNAL DRUGS AFFECTING FOETUS 12 0.0016
333 RESPIRATORY DISTRESS 43 0.0016
334 DEVELOPMENTAL DELAY 14 0.0016
335 ERUCTATION 30 0.0015
336 MENTAL STATUS CHANGES 43 0.0015
337 APHTHOUS ULCER 12 0.0015
338 PANCYTOPENIA 86 0.0015
339 BODY TEMPERATURE DECREASED 15 0.0015
340 BLOOD LACTIC ACID INCREASED 8 0.0015
341 SECRETION DISCHARGE 19 0.0015
342 OXYGEN SATURATION DECREASED 85 0.0015
343 FLUID OVERLOAD 22 0.0015
344 LIVER INJURY 37 0.0015
345 ATRIAL FLUTTER 12 0.0015
346 HEPATIC STEATOSIS 28 0.0015
347 EATING DISORDER 32 0.0015
348 CARDIAC MURMUR 13 0.0015
349 CARDIAC FAILURE ACUTE 10 0.0015
350 BLOOD DISORDER 12 0.0015
351 MUCOSAL INFLAMMATION 39 0.0015
352 MOTOR DYSFUNCTION 15 0.0015
353 HAEMOGLOBIN DECREASED 151 0.0015
354 ALANINE AMINOTRANSFERASE INCREASED 90 0.0015
355 ELECTROLYTE IMBALANCE 17 0.0015
356 HAEMATOCRIT DECREASED 29 0.0015
357 ESCHERICHIA INFECTION 12 0.0015
358 GENERALISED OEDEMA 18 0.0015
359 GASTROOESOPHAGEAL REFLUX DISEASE 117 0.0015
360 DIZZINESS POSTURAL 14 0.0014
361 EYE DISCHARGE 15 0.0014
362 SCIATICA 23 0.0014
363 LARGE INTESTINE PERFORATION 10 0.0014
364 THROMBOTIC MICROANGIOPATHY 14 0.0014
365 TOOTHACHE 26 0.0014
366 DEVICE RELATED INFECTION 22 0.0014
367 CONDITION AGGRAVATED 434 0.0014
368 RENAL TUBULAR NECROSIS 14 0.0014
369 PULMONARY ALVEOLAR HAEMORRHAGE 8 0.0014
370 CANDIDA INFECTION 24 0.0014
371 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 11 0.0014
372 MITRAL VALVE INCOMPETENCE 16 0.0014
373 ACUTE MYELOID LEUKAEMIA 22 0.0014
374 WHITE BLOOD CELL COUNT ABNORMAL 9 0.0014
375 MELAENA 31 0.0014
376 DIVERTICULUM 10 0.0014
377 POST PROCEDURAL COMPLICATION 27 0.0014
378 MULTIPLE ALLERGIES 11 0.0014
379 HYPOTONIA 14 0.0014
380 ELECTROCARDIOGRAM ABNORMAL 11 0.0014
381 PNEUMOTHORAX 22 0.0014
382 PANIC REACTION 10 0.0014
383 PULMONARY OEDEMA 62 0.0014
384 GINGIVAL PAIN 11 0.0014
385 LEUKOCYTOSIS 25 0.0014
386 ACUTE KIDNEY INJURY 211 0.0014
387 METABOLIC DISORDER 8 0.0014
388 TRANSPLANT REJECTION 11 0.0014
389 ORAL CANDIDIASIS 18 0.0014
390 HYPERTRIGLYCERIDAEMIA 8 0.0014
391 LUNG INFILTRATION 12 0.0014
392 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 12 0.0014
393 VENTRICULAR EXTRASYSTOLES 14 0.0013
394 BRAIN OEDEMA 17 0.0013
395 FAECES DISCOLOURED 29 0.0013
396 TRANSFUSION 14 0.0013
397 ULCER HAEMORRHAGE 9 0.0013
398 DYSPNOEA EXERTIONAL 50 0.0013
399 HYPOCALCAEMIA 25 0.0013
400 DERMATITIS ACNEIFORM 8 0.0013
401 CEREBRAL HAEMORRHAGE 47 0.0013
402 ONYCHOCLASIS 9 0.0013
403 JOINT EFFUSION 9 0.0013
404 INFUSION SITE ERYTHEMA 11 0.0013
405 CARDIO-RESPIRATORY ARREST 54 0.0013
406 VITAMIN D DECREASED 11 0.0013
407 HYPOTHERMIA 13 0.0013
408 ANURIA 11 0.0013
409 DEEP VEIN THROMBOSIS 83 0.0013
410 BRAIN FOG 20 0.0013
411 ASTHMA 144 0.0013
412 INFUSION SITE SWELLING 8 0.0013
413 PYELONEPHRITIS 11 0.0013
414 JOINT RANGE OF MOTION DECREASED 17 0.0013
415 VOMITING 595 0.0013
416 MUSCLE ATROPHY 16 0.0013
417 GASTROINTESTINAL DISORDER 113 0.0013
418 INTRAOCULAR PRESSURE INCREASED 16 0.0013
419 TENDERNESS 13 0.0012
420 PROCTALGIA 8 0.0012
421 CLOSTRIDIUM DIFFICILE INFECTION 27 0.0012
422 RECTAL HAEMORRHAGE 53 0.0012
423 SUDDEN DEATH 13 0.0012
424 TACHYCARDIA 109 0.0012
425 CYTOPENIA 15 0.0012
426 LUNG INFECTION 19 0.0012
427 DECREASED IMMUNE RESPONSIVENESS 12 0.0012
428 GASTROENTERITIS VIRAL 22 0.0012
429 LOWER GASTROINTESTINAL HAEMORRHAGE 9 0.0012
430 HEPATOTOXICITY 27 0.0012
431 VENTRICULAR TACHYCARDIA 20 0.0012
432 GASTRIC ULCER 23 0.0012
433 CYANOSIS 19 0.0012
434 APPETITE DISORDER 8 0.0012
435 EXOSTOSIS 11 0.0012
436 HYDRONEPHROSIS 9 0.0012
437 SEASONAL ALLERGY 17 0.0012
438 PULMONARY HYPERTENSION 25 0.0012
439 GRAND MAL CONVULSION 11 0.0012
440 BRADYCARDIA 63 0.0012
441 HYPOTENSION 238 0.0012
442 OSTEOPENIA 18 0.0012
443 PROCEDURAL COMPLICATION 9 0.0012
444 PLATELET COUNT DECREASED 125 0.0012
445 GASTROINTESTINAL HAEMORRHAGE 98 0.0012
446 VIRAL INFECTION 39 0.0012
447 RENAL FAILURE CHRONIC 9 0.0012
448 INFECTION 168 0.0012
449 COLITIS 44 0.0012
450 FOOT FRACTURE 22 0.0012
451 INTESTINAL PERFORATION 13 0.0012
452 CHROMATURIA 26 0.0012
453 HYPOMAGNESAEMIA 16 0.0011
454 RESPIRATORY SYNCYTIAL VIRUS INFECTION 10 0.0011
455 CYTOMEGALOVIRUS INFECTION 19 0.0011
456 DERMATITIS CONTACT 13 0.0011
457 DUODENAL ULCER 8 0.0011
458 BONE MARROW FAILURE 23 0.0011
459 SHOCK 26 0.0011
460 GASTRIC HAEMORRHAGE 13 0.0011
461 ATRIAL FIBRILLATION 110 0.0011
462 BODY TEMPERATURE INCREASED 23 0.0011
463 SKIN LACERATION 12 0.0011
464 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 53 0.0011
465 CYSTITIS 35 0.0011
466 ABNORMAL FAECES 9 0.0011
467 HEPATIC CYTOLYSIS 14 0.0011
468 EAR INFECTION 29 0.0011
469 PNEUMONIA BACTERIAL 10 0.0011
470 SPINAL COMPRESSION FRACTURE 9 0.0011
471 INCREASED TENDENCY TO BRUISE 10 0.0011
472 HYPERTENSION 230 0.0011
473 HAEMATURIA 37 0.0011
474 TOOTH ABSCESS 11 0.0011
475 RASH MACULO-PAPULAR 24 0.0011
476 LIVE BIRTH 9 0.0011
477 PYREXIA 371 0.0011
478 HAEMODIALYSIS 9 0.0011
479 ABSCESS 17 0.0011
480 POOR VENOUS ACCESS 11 0.0011
481 TOOTH INFECTION 14 0.0011
482 DIALYSIS 15 0.0011
483 PNEUMONIA 342 0.0011
484 SPINAL DISORDER 10 0.0011
485 HYPERTHERMIA 8 0.0010
486 MUSCULOSKELETAL DISCOMFORT 18 0.0010
487 LETHARGY 60 0.0010
488 MYOPATHY 9 0.0010
489 CHOLELITHIASIS 34 0.0010
490 RESPIRATORY DISORDER 31 0.0010
491 GASTROENTERITIS 15 0.0010
492 ORAL HERPES 20 0.0010
493 SPINAL OSTEOARTHRITIS 9 0.0010
494 PAIN IN JAW 29 0.0010
495 LYMPHOCYTE COUNT DECREASED 18 0.0010
496 HEPATIC FUNCTION ABNORMAL 38 0.0010
497 DYSPNOEA 576 0.0010
498 ACUTE MYOCARDIAL INFARCTION 30 0.0010
499 TUBULOINTERSTITIAL NEPHRITIS 19 0.0010
500 PRODUCT USE IN UNAPPROVED INDICATION 251 0.0010
501 DEHYDRATION 135 0.0010
502 IMMUNODEFICIENCY 15 0.0010
503 FEELING COLD 28 0.0010
504 MACULAR DEGENERATION 12 0.0010
505 DRUG INTERACTION 159 0.0010
506 PROTEINURIA 19 0.0010
507 PLATELET COUNT INCREASED 13 0.0010
508 MOUTH ULCERATION 21 0.0010
509 PERICARDIAL EFFUSION 23 0.0010
510 HYPERGLYCAEMIA 36 0.0010
511 ORAL PAIN 22 0.0010
512 RESPIRATORY DEPRESSION 12 0.0010
513 DYSURIA 36 0.0010
514 HEPATITIS 25 0.0010
515 EYE PAIN 55 0.0010
516 STATUS EPILEPTICUS 11 0.0010
517 HYPERCALCAEMIA 12 0.0010
518 DRUG EXPOSURE DURING PREGNANCY 33 0.0010
519 HYPERKALAEMIA 34 0.0010
520 AGRANULOCYTOSIS 18 0.0010
521 BLOOD TRIGLYCERIDES INCREASED 17 0.0010
522 ARTERIOSCLEROSIS 9 0.0010
523 INTESTINAL OBSTRUCTION 36 0.0010
524 GINGIVAL BLEEDING 13 0.0010
525 INFUSION RELATED REACTION 63 0.0009
526 NECK PAIN 53 0.0009
527 TREMOR 157 0.0009
528 COUGH 265 0.0009
529 PREMATURE DELIVERY 15 0.0009
530 MYDRIASIS 12 0.0009
531 PRODUCT CONTAINER ISSUE 8 0.0009
532 SINUS BRADYCARDIA 9 0.0009
533 UNRESPONSIVE TO STIMULI 24 0.0009
534 POOR QUALITY SLEEP 20 0.0009
535 AUTOIMMUNE DISORDER 9 0.0009
536 HAEMORRHOIDS 18 0.0009
537 RESPIRATORY TRACT INFECTION 24 0.0009
538 RENAL IMPAIRMENT 77 0.0009
539 OESOPHAGITIS 10 0.0009
540 METASTASES TO BONE 15 0.0009
541 BRONCHOSPASM 13 0.0009
542 LIGAMENT SPRAIN 9 0.0009
543 DEPRESSED LEVEL OF CONSCIOUSNESS 36 0.0009
544 SINUS DISORDER 18 0.0009
545 HAEMORRHAGE 95 0.0009
546 HYPOGLYCAEMIA 44 0.0009
547 DYSPHONIA 53 0.0009
548 DYSPEPSIA 89 0.0009
549 DENTAL CARIES 10 0.0009
550 PHOTOPHOBIA 17 0.0009
551 RENAL FAILURE 120 0.0009
552 BLOOD CREATINE PHOSPHOKINASE INCREASED 26 0.0009
553 TOOTH DISORDER 20 0.0009
554 CARDIAC ARREST 74 0.0009
555 LACTIC ACIDOSIS 29 0.0009
556 TOXIC SKIN ERUPTION 9 0.0009
557 GASTROINTESTINAL INFECTION 8 0.0009
558 MYOSITIS 8 0.0009
559 OCULAR DISCOMFORT 10 0.0009
560 ILEUS 11 0.0009
561 HEART RATE DECREASED 31 0.0009
562 PNEUMONITIS 24 0.0009
563 NAUSEA 696 0.0009
564 NEUTROPHIL COUNT INCREASED 9 0.0009
565 OBESITY 14 0.0009
566 EAR DISCOMFORT 9 0.0009
567 SCAR 15 0.0009
568 CELLULITIS 44 0.0009
569 SENSORY DISTURBANCE 14 0.0009
570 BLOOD PRESSURE SYSTOLIC INCREASED 17 0.0009
571 BONE PAIN 51 0.0009
572 URINARY RETENTION 29 0.0009
573 BLOOD POTASSIUM DECREASED 26 0.0009
574 WEIGHT DECREASED 241 0.0009
575 PETECHIAE 9 0.0009
576 NEUTROPENIA 117 0.0009
577 WEIGHT FLUCTUATION 9 0.0009
578 LIVER FUNCTION TEST ABNORMAL 25 0.0009
579 DIARRHOEA HAEMORRHAGIC 8 0.0009
580 FREQUENT BOWEL MOVEMENTS 23 0.0009
581 WHITE BLOOD CELL COUNT DECREASED 92 0.0008
582 PALLOR 23 0.0008
583 MUSCULOSKELETAL CHEST PAIN 13 0.0008
584 TENDONITIS 13 0.0008
585 THIRST 15 0.0008
586 RED BLOOD CELL COUNT DECREASED 24 0.0008
587 SLEEP APNOEA SYNDROME 16 0.0008
588 OFF LABEL USE 733 0.0008
589 DELIRIUM 29 0.0008
590 DECREASED ACTIVITY 9 0.0008
591 ELECTROCARDIOGRAM QT PROLONGED 30 0.0008
592 OEDEMA 45 0.0008
593 OSTEOMYELITIS 15 0.0008
594 APHASIA 25 0.0008
595 ADRENAL INSUFFICIENCY 10 0.0008
596 HEPATIC ENZYME INCREASED 56 0.0008
597 DISCOMFORT 50 0.0008
598 ASTHENIA 307 0.0008
599 HAEMATOCHEZIA 45 0.0008
600 ANAPHYLACTIC REACTION 45 0.0008
601 INFLAMMATION 42 0.0008
602 CONTUSION 78 0.0008
603 NEUTROPHIL COUNT DECREASED 33 0.0008
604 FEMUR FRACTURE 25 0.0008
605 BLADDER DISORDER 8 0.0008
606 NEPHROPATHY TOXIC 9 0.0008
607 RESPIRATORY ARREST 22 0.0008
608 GASTRITIS 21 0.0008
609 HEART RATE INCREASED 79 0.0008
610 MYOCARDIAL ISCHAEMIA 9 0.0008
611 HEAD DISCOMFORT 14 0.0008
612 SINUSITIS 81 0.0008
613 COORDINATION ABNORMAL 11 0.0008
614 FEELING JITTERY 15 0.0008
615 INSURANCE ISSUE 12 0.0008
616 ALTERED STATE OF CONSCIOUSNESS 17 0.0008
617 BLOOD PRESSURE DECREASED 52 0.0008
618 HYPOPHAGIA 20 0.0008
619 CEREBRAL INFARCTION 19 0.0008
620 ANOREXIA 10 0.0008
621 NIGHT SWEATS 25 0.0008
622 RHINORRHOEA 50 0.0008
623 CAESAREAN SECTION 9 0.0008
624 HIATUS HERNIA 10 0.0008
625 INTENTIONAL DOSE OMISSION 22 0.0008
626 EAR PAIN 15 0.0008
627 BONE DISORDER 14 0.0008
628 NEUROPATHY PERIPHERAL 73 0.0008
629 HEMIPARESIS 13 0.0008
630 DECREASED APPETITE 178 0.0008
631 STEVENS-JOHNSON SYNDROME 17 0.0008
632 KIDNEY INFECTION 15 0.0008
633 ECZEMA 40 0.0008
634 NEPHROLITHIASIS 35 0.0008
635 LYMPHADENOPATHY 27 0.0008
636 JOINT STIFFNESS 20 0.0008
637 MYELODYSPLASTIC SYNDROME 11 0.0008
638 PNEUMONIA ASPIRATION 19 0.0008
639 CHILLS 89 0.0008
640 IMMUNE SYSTEM DISORDER 10 0.0008
641 SNEEZING 17 0.0008
642 INCONTINENCE 8 0.0008
643 CHOLECYSTITIS 9 0.0008
644 OSTEOARTHRITIS 32 0.0008
645 OSTEOPOROSIS 31 0.0008
646 MYALGIA 128 0.0008
647 VISUAL ACUITY REDUCED 25 0.0008
648 MUSCLE RIGIDITY 9 0.0008
649 HEART RATE IRREGULAR 17 0.0008
650 WRIST FRACTURE 9 0.0008
651 RETCHING 16 0.0007
652 URINARY TRACT INFECTION 128 0.0007
653 OROPHARYNGEAL PAIN 69 0.0007
654 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 53 0.0007
655 PLASMA CELL MYELOMA 29 0.0007
656 BLOOD SODIUM DECREASED 14 0.0007
657 SKIN HAEMORRHAGE 11 0.0007
658 NEUROTOXICITY 13 0.0007
659 BURSITIS 9 0.0007
660 FATIGUE 577 0.0007
661 FLATULENCE 42 0.0007
662 MATERNAL EXPOSURE DURING PREGNANCY 66 0.0007
663 PRESYNCOPE 18 0.0007
664 METASTASES TO LIVER 13 0.0007
665 PHARYNGITIS STREPTOCOCCAL 8 0.0007
666 COLD SWEAT 13 0.0007
667 CARDIAC FAILURE CONGESTIVE 59 0.0007
668 WHITE BLOOD CELL COUNT INCREASED 28 0.0007
669 SKIN LESION 20 0.0007
670 PERIPHERAL COLDNESS 10 0.0007
671 DIARRHOEA 470 0.0007
672 GENERALISED TONIC-CLONIC SEIZURE 12 0.0007
673 DRUG LEVEL INCREASED 12 0.0007
674 PERITONITIS 15 0.0007
675 TINNITUS 33 0.0007
676 GAIT INABILITY 24 0.0007
677 CONFUSIONAL STATE 116 0.0007
678 RASH MACULAR 25 0.0007
679 RESTLESS LEGS SYNDROME 13 0.0007
680 COMA 34 0.0007
681 MENTAL DISORDER 31 0.0007
682 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 39 0.0007
683 MUSCULOSKELETAL PAIN 37 0.0007
684 SPEECH DISORDER 37 0.0007
685 CHOLECYSTECTOMY 8 0.0007
686 DEPRESSED MOOD 37 0.0007
687 INFLUENZA 78 0.0007
688 SKIN ULCER 18 0.0007
689 COVID-19 122 0.0007
690 ABDOMINAL PAIN UPPER 143 0.0007
691 BLISTER 39 0.0007
692 AGITATION 51 0.0007
693 INJECTION SITE INDURATION 9 0.0007
694 NERVOUSNESS 36 0.0007
695 HYPOTHYROIDISM 22 0.0007
696 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 124 0.0007
697 DISTURBANCE IN ATTENTION 37 0.0007
698 APATHY 10 0.0007
699 ARTHRALGIA 285 0.0007
700 MEMORY IMPAIRMENT 94 0.0007
701 NASAL CONGESTION 40 0.0007
702 BLOOD POTASSIUM INCREASED 11 0.0007
703 NEUROLEPTIC MALIGNANT SYNDROME 8 0.0007
704 BLOOD IRON DECREASED 8 0.0007
705 HEADACHE 421 0.0007
706 PRODUCT DOSE OMISSION IN ERROR 19 0.0007
707 NASOPHARYNGITIS 123 0.0007
708 BLOOD PRESSURE INCREASED 102 0.0007
709 PALPITATIONS 78 0.0007
710 STOMATITIS 40 0.0007
711 PAIN IN EXTREMITY 194 0.0007
712 NO THERAPEUTIC RESPONSE 8 0.0007
713 CHEST DISCOMFORT 67 0.0007
714 MOVEMENT DISORDER 21 0.0007
715 BLOOD PRESSURE ABNORMAL 13 0.0007
716 FEELING HOT 40 0.0007
717 MUSCLE TWITCHING 15 0.0007
718 CARDIOMEGALY 8 0.0006
719 EMOTIONAL DISORDER 20 0.0006
720 RHABDOMYOLYSIS 27 0.0006
721 LIMB DISCOMFORT 20 0.0006
722 PHARYNGITIS 8 0.0006
723 LABORATORY TEST ABNORMAL 19 0.0006
724 EJECTION FRACTION DECREASED 10 0.0006
725 MUSCLE SPASMS 118 0.0006
726 PERIPHERAL SWELLING 99 0.0006
727 MIDDLE INSOMNIA 12 0.0006
728 URINARY INCONTINENCE 19 0.0006
729 ABDOMINAL PAIN LOWER 16 0.0006
730 LOCAL SWELLING 11 0.0006
731 FUNGAL INFECTION 21 0.0006
732 RESPIRATORY TRACT CONGESTION 10 0.0006
733 EOSINOPHILIA 11 0.0006
734 CHEST PAIN 116 0.0006
735 PARAESTHESIA ORAL 9 0.0006
736 POLLAKIURIA 26 0.0006
737 BRONCHITIS 46 0.0006
738 INTERSTITIAL LUNG DISEASE 30 0.0006
739 GALLBLADDER DISORDER 11 0.0006
740 IRRITABILITY 37 0.0006
741 PRODUCT DOSE OMISSION ISSUE 180 0.0006
742 DEAFNESS 16 0.0006
743 BACK PAIN 142 0.0006
744 SKIN DISCOLOURATION 28 0.0006
745 BEDRIDDEN 8 0.0006
746 DISEASE PROGRESSION 72 0.0006
747 PRODUCT SUBSTITUTION ISSUE 35 0.0006
748 WEIGHT INCREASED 136 0.0006
749 FEELING ABNORMAL 144 0.0006
750 INSOMNIA 160 0.0006
751 HAIR TEXTURE ABNORMAL 8 0.0006
752 ALOPECIA 117 0.0006
753 PRODUCT PHYSICAL ISSUE 12 0.0006
754 FACE OEDEMA 10 0.0006
755 TASTE DISORDER 12 0.0006
756 CIRCULATORY COLLAPSE 10 0.0006
757 PANCREATITIS 31 0.0006
758 BURNING SENSATION 41 0.0006
759 CORONARY ARTERY OCCLUSION 8 0.0006
760 BLOOD PRESSURE FLUCTUATION 14 0.0006
761 GYNAECOMASTIA 18 0.0006
762 ANKLE FRACTURE 9 0.0006
763 DISORIENTATION 23 0.0006
764 BLOOD URINE PRESENT 11 0.0006
765 EXPOSURE DURING PREGNANCY 36 0.0006
766 IMPAIRED HEALING 19 0.0006
767 ABDOMINAL DISCOMFORT 97 0.0006
768 COGNITIVE DISORDER 27 0.0006
769 MENTAL IMPAIRMENT 14 0.0006
770 C-REACTIVE PROTEIN INCREASED 21 0.0006
771 NERVOUS SYSTEM DISORDER 18 0.0006
772 INCREASED APPETITE 11 0.0006
773 SEDATION 15 0.0006
774 MUSCULAR WEAKNESS 65 0.0006
775 DEVICE OCCLUSION 8 0.0006
776 HALLUCINATION, VISUAL 12 0.0006
777 HYPOAESTHESIA 85 0.0006
778 BALANCE DISORDER 49 0.0006
779 LYMPHOPENIA 8 0.0006
780 FLUSHING 57 0.0006
781 SYNCOPE 56 0.0006
782 HYPERHIDROSIS 72 0.0006
783 MUSCLE TIGHTNESS 9 0.0006
784 PAIN 341 0.0006
785 THROAT TIGHTNESS 15 0.0006
786 ILLNESS 57 0.0006
787 LIMB INJURY 15 0.0006
788 PULMONARY ARTERIAL HYPERTENSION 8 0.0006
789 COMPLICATION ASSOCIATED WITH DEVICE 8 0.0006
790 FLUID RETENTION 28 0.0005
791 INTERVERTEBRAL DISC PROTRUSION 12 0.0005
792 CARDIAC FAILURE 44 0.0005
793 ARTHRITIS 43 0.0005
794 PHOTOSENSITIVITY REACTION 9 0.0005
795 BLOOD GLUCOSE ABNORMAL 10 0.0005
796 CARDIOMYOPATHY 8 0.0005
797 DRUG WITHDRAWAL SYNDROME NEONATAL 8 0.0005
798 PARAESTHESIA 85 0.0005
799 LOCALISED INFECTION 13 0.0005
800 HEAD INJURY 17 0.0005
801 THROAT IRRITATION 24 0.0005
802 RIB FRACTURE 11 0.0005
803 ANHEDONIA 14 0.0005
804 VERTIGO 32 0.0005
805 DERMATITIS 11 0.0005
806 FEAR 14 0.0005
807 MALAISE 227 0.0005
808 RASH 225 0.0005
809 NEEDLE ISSUE 15 0.0005
810 DYSSTASIA 15 0.0005
811 INTENTIONAL PRODUCT USE ISSUE 45 0.0005
812 IRRITABLE BOWEL SYNDROME 11 0.0005
813 ANXIETY 146 0.0005
814 SURGERY 30 0.0005
815 SKIN DISORDER 17 0.0005
816 DIABETES MELLITUS INADEQUATE CONTROL 9 0.0005
817 DIVERTICULITIS 14 0.0005
818 ACTIVITIES OF DAILY LIVING IMPAIRED 10 0.0005
819 ISCHAEMIC STROKE 9 0.0005
820 WOUND 14 0.0005
821 DIPLOPIA 13 0.0005
822 LEUKOPENIA 25 0.0005
823 FULL BLOOD COUNT DECREASED 10 0.0005
824 PRODUCT ADMINISTRATION ERROR 10 0.0005
825 BACK DISORDER 8 0.0005
826 RASH PAPULAR 11 0.0005
827 NEOPLASM PROGRESSION 17 0.0005
828 JOINT SWELLING 59 0.0005
829 GAIT DISTURBANCE 93 0.0005
830 CONJUNCTIVITIS 9 0.0005
831 DEPRESSION 110 0.0005
832 PAIN OF SKIN 13 0.0005
833 RASH ERYTHEMATOUS 23 0.0005
834 BLOOD GLUCOSE DECREASED 23 0.0005
835 BONE DENSITY DECREASED 15 0.0005
836 FALL 159 0.0005
837 HOT FLUSH 36 0.0005
838 PERICARDITIS 8 0.0005
839 TREATMENT NONCOMPLIANCE 26 0.0005
840 ANGER 16 0.0005
841 CATARACT 28 0.0005
842 SEROTONIN SYNDROME 9 0.0005
843 LOSS OF CONSCIOUSNESS 60 0.0005
844 PSORIATIC ARTHROPATHY 19 0.0005
845 THERAPY CESSATION 24 0.0005
846 SEIZURE 54 0.0005
847 GLAUCOMA 9 0.0005
848 THERAPY NON-RESPONDER 21 0.0005
849 VISION BLURRED 64 0.0005
850 LACRIMATION INCREASED 14 0.0005
851 CHOKING 9 0.0005
852 DRY EYE 23 0.0005
853 PRURITUS 177 0.0005
854 MOBILITY DECREASED 33 0.0005
855 DYSPHAGIA 43 0.0005
856 FIBROMYALGIA 11 0.0005
857 UPPER LIMB FRACTURE 9 0.0005
858 DYSARTHRIA 17 0.0005
859 MIGRAINE 43 0.0004
860 INFLUENZA LIKE ILLNESS 37 0.0004
861 PREGNANCY 9 0.0004
862 UNEVALUABLE EVENT 34 0.0004
863 DIZZINESS 223 0.0004
864 TOXICITY TO VARIOUS AGENTS 75 0.0004
865 ARRHYTHMIA 21 0.0004
866 RASH PRURITIC 24 0.0004
867 ERYTHEMA 91 0.0004
868 OCULAR HYPERAEMIA 21 0.0004
869 CRYING 16 0.0004
870 SKIN EXFOLIATION 37 0.0004
871 VAGINAL HAEMORRHAGE 19 0.0004
872 GASTRIC DISORDER 15 0.0004
873 HERPES ZOSTER 25 0.0004
874 EYE IRRITATION 25 0.0004
875 CONTRAINDICATED PRODUCT ADMINISTERED 13 0.0004
876 ILL-DEFINED DISORDER 26 0.0004
877 ANAPHYLACTIC SHOCK 11 0.0004
878 THERAPEUTIC RESPONSE UNEXPECTED 19 0.0004
879 FRACTURE 8 0.0004
880 CHRONIC KIDNEY DISEASE 32 0.0004
881 IMPAIRED WORK ABILITY 9 0.0004
882 HYPERSENSITIVITY 78 0.0004
883 DRY SKIN 56 0.0004
884 PRODUCT DISPENSING ERROR 9 0.0004
885 PANIC ATTACK 15 0.0004
886 RESTLESSNESS 15 0.0004
887 DRUG INEFFECTIVE 537 0.0004
888 CARDIAC DISORDER 38 0.0004
889 THERAPY INTERRUPTED 29 0.0004
890 NIGHTMARE 14 0.0004
891 HIP FRACTURE 13 0.0004
892 CONVULSION 23 0.0004
893 GLOSSODYNIA 9 0.0004
894 HYPOACUSIS 17 0.0004
895 SUICIDAL IDEATION 36 0.0004
896 THERAPEUTIC RESPONSE SHORTENED 13 0.0004
897 MALIGNANT NEOPLASM PROGRESSION 40 0.0004
898 TARDIVE DYSKINESIA 11 0.0004
899 EYE PRURITUS 13 0.0004
900 RASH GENERALISED 10 0.0004
901 AMNESIA 25 0.0004
902 SWOLLEN TONGUE 12 0.0004
903 INJURY 27 0.0004
904 HYPERSOMNIA 11 0.0004
905 ROAD TRAFFIC ACCIDENT 16 0.0004
906 URTICARIA 64 0.0004
907 APPLICATION SITE ERYTHEMA 10 0.0004
908 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 27 0.0004
909 INJECTION SITE MASS 14 0.0004
910 ABNORMAL BEHAVIOUR 15 0.0004
911 BLOOD GLUCOSE INCREASED 70 0.0004
912 DYSKINESIA 15 0.0004
913 MOOD ALTERED 10 0.0004
914 EYE DISORDER 12 0.0004
915 RENAL DISORDER 17 0.0004
916 ABASIA 9 0.0004
917 OSTEONECROSIS OF JAW 9 0.0004
918 PRODUCT USE ISSUE 68 0.0004
919 HOSPITALISATION 55 0.0004
920 MULTIPLE SCLEROSIS 17 0.0004
921 VISUAL IMPAIRMENT 44 0.0004
922 DEATH 304 0.0004
923 EYE SWELLING 13 0.0003
924 ANGINA PECTORIS 10 0.0003
925 PHARMACEUTICAL PRODUCT COMPLAINT 9 0.0003
926 THERAPEUTIC RESPONSE DECREASED 21 0.0003
927 ARTHROPATHY 19 0.0003
928 INJECTION SITE HAEMORRHAGE 27 0.0003
929 PRODUCT PRESCRIBING ERROR 8 0.0003
930 MYELOSUPPRESSION 12 0.0003
931 NEOPLASM MALIGNANT 22 0.0003
932 EPILEPSY 10 0.0003
933 DRUG ADMINISTRATION ERROR 10 0.0003
934 EXTRAPYRAMIDAL DISORDER 8 0.0003
935 OVERDOSE 69 0.0003
936 SYSTEMIC LUPUS ERYTHEMATOSUS 11 0.0003
937 WITHDRAWAL SYNDROME 13 0.0003
938 SWELLING FACE 20 0.0003
939 CEREBROVASCULAR ACCIDENT 52 0.0003
940 MEDICATION ERROR 17 0.0003
941 OSTEONECROSIS 10 0.0003
942 DRUG EFFECT INCOMPLETE 11 0.0003
943 INJECTION SITE PRURITUS 20 0.0003
944 INJECTION SITE RASH 9 0.0003
945 HALLUCINATION 22 0.0003
946 PROCEDURAL PAIN 8 0.0003
947 INJECTION SITE BRUISING 23 0.0003
948 DEMENTIA 8 0.0003
949 INJECTION SITE PAIN 87 0.0003
950 PRODUCT QUALITY ISSUE 38 0.0003
951 ACNE 21 0.0003
952 INJECTION SITE REACTION 19 0.0003
953 ACCIDENTAL OVERDOSE 10 0.0003
954 LIP SWELLING 9 0.0003
955 DERMATITIS ATOPIC 14 0.0003
956 AGGRESSION 13 0.0003
957 DYSGEUSIA 19 0.0003
958 DEVICE DISLOCATION 11 0.0003
959 MOOD SWINGS 8 0.0003
960 TREATMENT FAILURE 20 0.0002
961 DRUG EFFECT DECREASED 13 0.0002
962 EXPIRED PRODUCT ADMINISTERED 8 0.0002
963 ADVERSE EVENT 21 0.0002
964 RHEUMATOID ARTHRITIS 25 0.0002
965 UNDERDOSE 16 0.0002
966 INTENTIONAL OVERDOSE 14 0.0002
967 BREAST CANCER 19 0.0002
968 ADVERSE DRUG REACTION 18 0.0002
969 ABORTION SPONTANEOUS 8 0.0002
970 PRODUCT DOSE OMISSION 13 0.0002
971 DEVICE BREAKAGE 8 0.0002
972 BLINDNESS 8 0.0002
973 INCORRECT DOSE ADMINISTERED 43 0.0002
974 DEVICE LEAKAGE 8 0.0002
975 ANGIOEDEMA 8 0.0002
976 MYOCARDIAL INFARCTION 31 0.0002
977 MULTIPLE SCLEROSIS RELAPSE 12 0.0002
978 DEVICE MALFUNCTION 12 0.0002
979 DISEASE RECURRENCE 8 0.0002
980 SKIN BURNING SENSATION 12 0.0002
981 EMOTIONAL DISTRESS 20 0.0002
982 DRUG DOSE OMISSION 27 0.0002
983 INJECTION SITE ERYTHEMA 20 0.0002
984 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 31 0.0002
985 NO ADVERSE EVENT 27 0.0001
986 SUICIDE ATTEMPT 9 0.0001
987 DEVICE ISSUE 13 0.0001
988 PSORIASIS 18 0.0001
989 PRODUCT STORAGE ERROR 12 0.0001
990 INJECTION SITE SWELLING 10 0.0001
991 ACCIDENTAL EXPOSURE TO PRODUCT 13 0.0001
992 PROSTATE CANCER 9 0.0001
993 DRUG WITHDRAWAL SYNDROME 8 0.0001